These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24523403)

  • 1. Identification of the distance between the homologous halves of P-glycoprotein that triggers the high/low ATPase activity switch.
    Loo TW; Clarke DM
    J Biol Chem; 2014 Mar; 289(12):8484-92. PubMed ID: 24523403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATPase activity of the P-glycoprotein drug pump is highly activated when the N-terminal and central regions of the nucleotide-binding domains are linked closely together.
    Loo TW; Bartlett MC; Detty MR; Clarke DM
    J Biol Chem; 2012 Aug; 287(32):26806-16. PubMed ID: 22700974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteines introduced into extracellular loops 1 and 4 of human P-glycoprotein that are close only in the open conformation spontaneously form a disulfide bond that inhibits drug efflux and ATPase activity.
    Loo TW; Clarke DM
    J Biol Chem; 2014 Sep; 289(36):24749-58. PubMed ID: 25053414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human P-glycoprotein is active when the two halves are clamped together in the closed conformation.
    Loo TW; Bartlett MC; Clarke DM
    Biochem Biophys Res Commun; 2010 May; 395(3):436-40. PubMed ID: 20394729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attachment of a 'molecular spring' restores drug-stimulated ATPase activity to P-glycoprotein lacking both Q loop glutamines.
    Loo TW; Clarke DM
    Biochem Biophys Res Commun; 2017 Jan; 483(1):366-370. PubMed ID: 28025146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locking intracellular helices 2 and 3 together inactivates human P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 2014 Jan; 289(1):229-36. PubMed ID: 24275649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing mutations located throughout the human multidrug resistance P-glycoprotein disrupt interactions between the nucleotide binding domains.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2004 Sep; 279(37):38395-401. PubMed ID: 15247215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A short cross-linker activates human P-glycoprotein missing a catalytic carboxylate.
    Loo TW; Clarke DM
    Biochem Pharmacol; 2017 Dec; 145():27-33. PubMed ID: 28837794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites.
    Ohnuma S; Chufan E; Nandigama K; Jenkins LM; Durell SR; Appella E; Sauna ZE; Ambudkar SV
    Biochemistry; 2011 May; 50(18):3724-35. PubMed ID: 21452853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human P-glycoprotein contains a greasy ball-and-socket joint at the second transmission interface.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2013 Jul; 288(28):20326-33. PubMed ID: 23733192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug binding in human P-glycoprotein causes conformational changes in both nucleotide-binding domains.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2003 Jan; 278(3):1575-8. PubMed ID: 12421806
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Futamata R; Ogasawara F; Ichikawa T; Kodan A; Kimura Y; Kioka N; Ueda K
    J Biol Chem; 2020 Apr; 295(15):5002-5011. PubMed ID: 32111736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conserved Walker A cysteines 431 and 1074 in human P-glycoprotein are accessible to thiol-specific agents in the apo and ADP-vanadate trapped conformations.
    Sim HM; Bhatnagar J; Chufan EE; Kapoor K; Ambudkar SV
    Biochemistry; 2013 Oct; 52(41):7327-38. PubMed ID: 24053441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both ATP sites of human P-glycoprotein are essential but not symmetric.
    Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM
    Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis.
    Zoghbi ME; Mok L; Swartz DJ; Singh A; Fendley GA; Urbatsch IL; Altenberg GA
    J Biol Chem; 2017 Dec; 292(50):20412-20424. PubMed ID: 29018094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein ATPase activity requires lipids to activate a switch at the first transmission interface.
    Loo TW; Clarke DM
    Biochem Biophys Res Commun; 2016 Apr; 472(2):379-83. PubMed ID: 26944019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2004 Feb; 279(9):7692-7. PubMed ID: 14670948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Val133 and Cys137 in transmembrane segment 2 are close to Arg935 and Gly939 in transmembrane segment 11 of human P-glycoprotein.
    Loo TW; Bartlett MC; Clarke DM
    J Biol Chem; 2004 Apr; 279(18):18232-8. PubMed ID: 14749322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Insights into Allosteric Conformational Modulation of P-Glycoprotein by Substrate and Inhibitor Binding.
    Xing J; Huang S; Heng Y; Mei H; Pan X
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33353070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic transitions in the human MDR1 P-glycoprotein drug binding sites.
    Wise JG
    Biochemistry; 2012 Jun; 51(25):5125-41. PubMed ID: 22647192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.